Genmab — Maj 2019

peter12

De har nok skumle planer ...

E_L

I actually thought Ixazomib and bortezomib are sort of similar, both proteasome inhibitors , did not expect them to be used together

Plimsoller

(borsen.dk)

ienk1

Marshall Wace LLP has reduced his short position to 303580 shares issued by Genmab A/S 14/02 2019

Bulder

E L, you can see the explanation in experimental arm II. They don't get isa and bor at the same time.

E_L

ok, thks, i see it now

Bulder

+6 kroner på en lukkeauktion. Det er vist rekord.

Helge_LarsenPI-redaktør

E_L

jkj

nøgletal lidt dårligere end forventet

jkj

Den skal tales godt op til q&A ellers er der ingen belønning.

Helge_LarsenPI-redaktør

Regnskabet er inden for skiven.

jkj

jeg syndes det er skræmmende at cashburn er blevet så stort at der ikke kan laves et plus.

E_L

so if they had slowed down their work and hiring just to get a small plus you would have been happier...?

Legolas23

Børsen i vanlig prosa

Legolas23

(borsen.dk)

Legolas23

jkj

Det kort svar EL er ja, og jeg er næppe alene med den holdning.

Bulder

Det er du helt sikkert ikke. Og kursen skal smen nok blive handlet ned i morgen på det minus.

gentogen

Net result for the first quarter of 2019 was a net income of DKK 72 million